(Q41438173)

English

Pediatric Oncology Group Utilization of Immunologic Markers in the Designation of Acute Lymphocytic Leukemia Subgroups: Influence on Treatment Response

scientific article published on January 1, 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Pediatric oncology group utilization of immunologic markers in the designation of acute lymphocytic leukemia subgroups: influence on treatment response (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Pediatric Oncology Group Utilization of Immunologic Markers in the Designation of Acute Lymphocytic Leukemia Subgroups: Influence on Treatment Response (English)

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

0 references

1 reference

based on heuristic

inferred from title

acute lymphocytic leukemia

1 reference

based on heuristic

inferred from title

history and philosophy of science

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

author name string

D. J. Pullen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6234834

3 September 2023

J. M. Boyett

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6234834

3 September 2023

W. M. Crist

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6234834

3 September 2023

J. M. Falletta

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6234834

3 September 2023

M. Roper

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6234834

3 September 2023

B. Dowell

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6234834

3 September 2023

J. Van Eys

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6234834

3 September 2023

J. F. Jackson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6234834

3 September 2023

G. B. Humphrey

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6234834

3 September 2023

R. S. Metzgar

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6234834

3 September 2023

language of work or name

0 references

publication date

1 January 1984

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1984.tb12280.x

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1984.tb12280.x/fullpdf

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Annals of the New York Academy of Sciences

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

428

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

26-48

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Agammaglobulinaemia with B lymphocytes. Specific defect of plasma-cell differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB12280.X

21 January 2018

Acute lymphocytic leukemia in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB12280.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB12280.X

21 January 2018

Acute lymphoblastic leukaemia in children: Classification and prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB12280.X

21 January 2018

Lymphocytic leukemia in children: Prognostic significance of clinical and laboratory findings at time of diagnosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB12280.X

21 January 2018

Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB12280.X

21 January 2018

Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB12280.X

21 January 2018

Effective therapy for Burkitt's lymphoma: High-dose cyclophosphamide + high-dose methotrexate with coordinated intrathecal therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB12280.X

21 January 2018

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations

2

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Cancer Research

6

38

3616

author name string

Richie E. R.

publication date

1978

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Cancer Research

12

41

4781

author name string

Metzgar R. S.

publication date

1981

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Detection and partial characterization of human thymus-leukemia antigens

13

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia

15

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Factors influencing survival in pediatric acute leukemia.The SWCCSG experience, 1958–1970

16

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Cancer Research

29

41

4802

author name string

Pullen D. J.

publication date

1981

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Clinical importance of lymphoblasts with T markers in childhood acute leukemia

32

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Surface Markers and Prognostic Factors in Acute Lymphoblastic Leukemia

33

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Prognostic significance of surface marker analysis in childhood non-Hodgkin's lymphoproliferative malifnancies

34

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Prognostic significance of cell surface markers in childhood acute lymphoblastic leukaemia

38

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Cancer Research

46

41

4752

author name string

Greaves M. F.

publication date

1981

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Cancer Research

47

41

4794

author name string

Bowman W. P.

publication date

1981

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience

51

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Cytogenetics of B-cell lineage acute lymphocytic leukaemias of childhood

55

1 reference

10.1111/J.1749-6632.1984.TB12280.X

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB12280.X

3 September 2023

Identifiers

10.1111/J.1749-6632.1984.TB12280.X

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41438173&oldid=1967361050"